These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24877104)

  • 21. Urothelial carcinomas arising in arsenic-contaminated areas are associated with hypermethylation of the gene promoter of the death-associated protein kinase.
    Chen WT; Hung WC; Kang WY; Huang YC; Chai CY
    Histopathology; 2007 Dec; 51(6):785-92. PubMed ID: 17953697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic down-regulation of death-associated protein kinase in lung cancers.
    Toyooka S; Toyooka KO; Miyajima K; Reddy JL; Toyota M; Sathyanarayana UG; Padar A; Tockman MS; Lam S; Shivapurkar N; Gazdar AF
    Clin Cancer Res; 2003 Aug; 9(8):3034-41. PubMed ID: 12912953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oligodendroglioma with neurocytic differentiation versus atypical extraventricular neurocytoma: a case report of unusual pathologic findings of a spinal cord tumor.
    Makuria AT; Henderson FC; Rushing EJ; Hartmann DP; Azumi N; Ozdemirli M
    J Neurooncol; 2007 Apr; 82(2):199-205. PubMed ID: 17039400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic differences between neurocytoma and dysembryoplastic neuroepithelial tumor and oligodendroglial tumors.
    Fujisawa H; Marukawa K; Hasegawa M; Tohma Y; Hayashi Y; Uchiyama N; Tachibana O; Yamashita J
    J Neurosurg; 2002 Dec; 97(6):1350-5. PubMed ID: 12507133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between promoter methylation of p14(ARF), TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma.
    Xiaofang L; Kun T; Shaoping Y; Zaiqiu W; Hailong S
    World J Surg Oncol; 2012 Jan; 10():5. PubMed ID: 22230750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients.
    Buckingham L; Penfield Faber L; Kim A; Liptay M; Barger C; Basu S; Fidler M; Walters K; Bonomi P; Coon J
    Int J Cancer; 2010 Apr; 126(7):1630-9. PubMed ID: 19795445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequent intra-tumoural heterogeneity of promoter hypermethylation in malignant melanoma.
    Rastetter M; Schagdarsurengin U; Lahtz C; Fiedler E; Marsch WCh; Dammann R; Helmbold P
    Histol Histopathol; 2007 Sep; 22(9):1005-15. PubMed ID: 17523078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma.
    Kuester D; Guenther T; Biesold S; Hartmann A; Bataille F; Ruemmele P; Peters B; Meyer F; Schubert D; Bohr UR; Malfertheiner P; Lippert H; Silver AR; Roessner A; Schneider-Stock R
    Pathol Res Pract; 2010 Sep; 206(9):616-24. PubMed ID: 20630662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcription control of DAPK.
    Benderska N; Schneider-Stock R
    Apoptosis; 2014 Feb; 19(2):298-305. PubMed ID: 24217921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter hypermethylation of death-associated protein kinase and p16 genes in vulvar lichen sclerosus.
    Aidé S; Lattario FR; Almeida G; do Val IC; Carvalho Mda G
    J Low Genit Tract Dis; 2012 Apr; 16(2):133-9. PubMed ID: 22371043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenging diagnosis: oligodendroglioma versus extraventricular neurocytoma.
    Mut M; Güler-Tezel G; Lopes MB; Bilginer B; Ziyal I; Ozcan OE
    Clin Neuropathol; 2005; 24(5):225-9. PubMed ID: 16167546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual promoter regulation of death-associated protein kinase gene leads to differentially silenced transcripts by methylation in cancer.
    Pulling LC; Grimes MJ; Damiani LA; Juri DE; Do K; Tellez CS; Belinsky SA
    Carcinogenesis; 2009 Dec; 30(12):2023-30. PubMed ID: 19917631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of death-associated protein kinase gene and methylation status of promoter region in acute leukemia].
    Niu YM; Wang PP; Wang Y; Wang YZ; Cai DL; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):30-4. PubMed ID: 24598646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Promoter methylation and expression of death-associated protein kinase gene in acute leukemia].
    Zhao WH; Meng FY; Lai YR; Peng ZG; Ma J
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Mar; 37(3):407-410. PubMed ID: 28377362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical effect of DAPK promoter methylation in gastric cancer: A systematic meta-analysis.
    Jia W; Yu T; Cao X; An Q; Yang H
    Medicine (Baltimore); 2016 Oct; 95(43):e5040. PubMed ID: 27787359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoter methylation of death-associated protein kinase and its role in irradiation response in cervical cancer.
    Leung RC; Liu SS; Chan KY; Tam KF; Chan KL; Wong LC; Ngan HY
    Oncol Rep; 2008 May; 19(5):1339-45. PubMed ID: 18425396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter hypermethylation patterns of P16, DAPK and MGMT in oral squamous cell carcinoma: a systematic review and meta-analysis.
    Don KR; Ramani P; Ramshankar V; Sherlin HJ; Premkumar P; Natesan A
    Indian J Dent Res; 2014; 25(6):797-805. PubMed ID: 25728117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoter hypermethylation of PTPL1, PTPN6, DAPK, p16 and 5-azacitidine inhibits growth in DLBCL.
    Wang W; Wang J; Li Z; Zhu M; Zhang Z; Wang Y; Jing H
    Oncol Rep; 2016 Jan; 35(1):139-46. PubMed ID: 26498513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications.
    Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Köllermann J; Miller K; Schrader M
    Clin Cancer Res; 2006 Sep; 12(17):5040-6. PubMed ID: 16951219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
    Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M
    Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.